Sight Sciences (SGHT)
NASDAQ:SGHT
Want to see SGHT full AI Analyst Report?
Earnings Data
Report Date
Aug 06, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.15Last Year’s EPS
-0.23Same Quarter Last Year
Moderate Buy
Based on 8 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented a largely positive operational and financial picture: the company returned to double‑digit revenue growth, raised 2026 revenue guidance, showed meaningful early traction in the newly reimbursed Interventional Dry Eye market, sustained very strong gross margins, and demonstrated improved cash usage and lower adjusted operating expenses. Challenges remain—most notably continued net losses, concentrated payer coverage for TearCare, early penetration of the dry eye opportunity, and uncertainty around timing of cash from the legal judgment—but these risks were framed as manageable and addressable with targeted commercial investment. On balance the positive progress, guidance raise, margin strength, and improving cash dynamics outweigh the outstanding risks.Company Guidance
Return to Double‑Digit Revenue Growth
Total revenue for Q1 2026 was $19.7M, up 13% year‑over‑year, led by growth in both Interventional Glaucoma and Interventional Dry Eye.
Interventional Glaucoma Growth and Momentum
Interventional Glaucoma revenue was $18.3M, a 7% increase year‑over‑year; ordering accounts grew 6% YoY and 1% sequentially. This marked the third consecutive quarter of YoY growth and strong March momentum.
Early Commercial Traction in Interventional Dry Eye
Interventional Dry Eye revenue was $1.4M (up from $400K), nearly doubling sequentially. ~1,500 SmartLids sold in Q1 vs ~700 previously (~114% increase), with 96 active accounts and average SmartLids utilization per active account rising from 9 to ~16 (~78% increase). About half of active accounts came from the existing glaucoma customer base, showing cross‑sell synergies.
Raised 2026 Revenue Guidance
Full‑year 2026 revenue guidance increased to $83M–$89M (7%–15% growth vs 2025). Interventional Glaucoma guidance of $77M–$81M (2%–7% growth) and Interventional Dry Eye guidance of $6M–$8M (vs $1.6M prior year) were provided.
Strong Gross Margins
Overall gross margin remained robust at 86% (flat YoY). Interventional Glaucoma margin was 87% and Interventional Dry Eye margin improved to 72% (from 71%).
Improved Operating Discipline
Adjusted operating expenses were $21.2M, down 14% YoY. Excluding a one‑time $5.4M item tied to the litigation judgment, operating expenses fell ~17%, reflecting earlier workforce reductions and cost control.
Improved Cash Usage and Path to Breakeven
Cash used in the quarter was $7M, down from $11.6M in the prior year quarter (a ~40% reduction). Cash and equivalents ended the quarter at $85M. Management reiterated a path to cash‑flow breakeven without raising equity.
Favorable Legal Ruling (Potential Financial Upside)
Court upheld a judgment against Alcon confirming past damages, interest and royalties totaling approximately $55M and ongoing royalties of 10% of Hydrus revenue through patent expiration; ruling is subject to appeal and no cash has been received to date.
SGHT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SGHT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 06, 2026 | $4.30 | $5.29 | +23.02% |
Mar 04, 2026 | $5.41 | $3.96 | -26.80% |
Nov 06, 2025 | $5.00 | $5.82 | +16.40% |
Aug 07, 2025 | $3.55 | $4.24 | +19.44% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Sight Sciences (SGHT) report earnings?
Sight Sciences (SGHT) is schdueled to report earning on Aug 06, 2026, After Close (Confirmed).
What is Sight Sciences (SGHT) earnings time?
Sight Sciences (SGHT) earnings time is at Aug 06, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SGHT EPS forecast?
SGHT EPS forecast for the fiscal quarter 2026 (Q2) is -0.15.